Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

June 01, 2015; Volume 43,Issue 6

Short Communication

  • You have access
    Inflammation-Associated MicroRNA-130b Down-Regulates Cytochrome P450 Activities and Directly Targets CYP2C9
    Jessica K. Rieger, Sandra Reutter, Ute Hofmann, Matthias Schwab and Ulrich M. Zanger
    Drug Metabolism and Disposition June 2015, 43 (6) 884-888; DOI: https://doi.org/10.1124/dmd.114.062844

Accelerated Communication

  • You have access
    Use of Transgenic Mouse Models to Understand the Oral Disposition and Drug-Drug Interaction Potential of Cobimetinib, a MEK Inhibitor
    Edna F. Choo, Sarah Woolsey, Kevin DeMent, Justin Ly, Kirsten Messick, Ann Qin and Ryan Takahashi
    Drug Metabolism and Disposition June 2015, 43 (6) 864-869; DOI: https://doi.org/10.1124/dmd.115.063743

Articles

  • You have access
    Mechanistic Investigation of the Preclinical Pharmacokinetics and Interspecies Scaling of PF-05231023, a Fibroblast Growth Factor 21–Antibody Protein Conjugate
    Craig Giragossian, Chandra Vage, Jun Li, Kathleen Pelletier, Nicole Piché-Nicholas, Manoj Rajadhyaksha, Jennifer Liras, Alison Logan, Roberto A. Calle and Yan Weng
    Drug Metabolism and Disposition June 2015, 43 (6) 803-811; DOI: https://doi.org/10.1124/dmd.114.061713
  • You have access
    Targeted Screen for Human UDP-Glucuronosyltransferases Inhibitors and the Evaluation of Potential Drug-Drug Interactions with Zafirlukast
    Shingo Oda, Ryoichi Fujiwara, Yuki Kutsuno, Tatsuki Fukami, Tomoo Itoh, Tsuyoshi Yokoi and Miki Nakajima
    Drug Metabolism and Disposition June 2015, 43 (6) 812-818; DOI: https://doi.org/10.1124/dmd.114.062141
  • You have access
    Short-Term Fasting Alters Cytochrome P450–Mediated Drug Metabolism in Humans
    Laureen A. Lammers, Roos Achterbergh, Emmely M. de Vries, F. Samuel van Nierop, Heinz-Josef Klümpen, Maarten R. Soeters, Anita Boelen, Johannes A. Romijn and Ron A. A. Mathôt
    Drug Metabolism and Disposition June 2015, 43 (6) 819-828; DOI: https://doi.org/10.1124/dmd.114.062299
  • You have access
    Altered Regulation of Hepatic Efflux Transporters Disrupts Acetaminophen Disposition in Pediatric Nonalcoholic Steatohepatitis
    Mark J. Canet, Matthew D. Merrell, Rhiannon N. Hardwick, Amy M. Bataille, Sarah N. Campion, Daniel W. Ferreira, Stavra A. Xanthakos, Jose E. Manautou, H. Hesham A-Kader, Robert P. Erickson and Nathan J. Cherrington
    Drug Metabolism and Disposition June 2015, 43 (6) 829-835; DOI: https://doi.org/10.1124/dmd.114.062703
  • You have access
    Prediction of Gestational Age–Dependent Induction of In Vivo Hepatic CYP3A Activity Based on HepaRG Cells and Human Hepatocytes
    Zufei Zhang, Muhammad Farooq, Bhagwat Prasad, Sue Grepper and Jashvant D. Unadkat
    Drug Metabolism and Disposition June 2015, 43 (6) 836-842; DOI: https://doi.org/10.1124/dmd.114.062984
  • You have access
    The Effects of Endoxifen and Other Major Metabolites of Tamoxifen on the Sulfation of Estradiol Catalyzed by Human Cytosolic Sulfotransferases hSULT1E1 and hSULT1A1*1
    Edwin J. Squirewell and Michael W. Duffel
    Drug Metabolism and Disposition June 2015, 43 (6) 843-850; DOI: https://doi.org/10.1124/dmd.115.063206
  • You have access
    Evaluation of Cynomolgus Monkeys for the Identification of Endogenous Biomarkers for Hepatic Transporter Inhibition and as a Translatable Model to Predict Pharmacokinetic Interactions with Statins in Humans
    Xiaoyan Chu, Shian-Jiun Shih, Rachel Shaw, Hannes Hentze, Grace H. Chan, Karen Owens, Shubing Wang, Xiaoxin Cai, Deborah Newton, Jose Castro-Perez, Gino Salituro, Jairam Palamanda, Aaron Fernandis, Choon Keow Ng, Andy Liaw, Mary J. Savage and Raymond Evers
    Drug Metabolism and Disposition June 2015, 43 (6) 851-863; DOI: https://doi.org/10.1124/dmd.115.063347
  • You have access
    Prediction of In Vivo Clearance and Associated Variability of CYP2C19 Substrates by Genotypes in Populations Utilizing a Pharmacogenetics-Based Mechanistic Model
    Boyd Steere, Jessica A. Roseberry Baker, Stephen D. Hall and Yingying Guo
    Drug Metabolism and Disposition June 2015, 43 (6) 870-883; DOI: https://doi.org/10.1124/dmd.114.061523
  • You have access
    Induction of UDP-Glucuronosyltransferase 2B15 Gene Expression by the Major Active Metabolites of Tamoxifen, 4-Hydroxytamoxifen and Endoxifen, in Breast Cancer Cells
    Apichaya Chanawong, Dong Gui Hu, Robyn Meech, Peter I. Mackenzie and Ross A. McKinnon
    Drug Metabolism and Disposition June 2015, 43 (6) 889-897; DOI: https://doi.org/10.1124/dmd.114.062935
  • You have access
    Biodistribution of Etanercept to Tissues and Sites of Inflammation in Arthritic Rats
    Xi Chen, Debra C. DuBois, Richard R. Almon and William J. Jusko
    Drug Metabolism and Disposition June 2015, 43 (6) 898-907; DOI: https://doi.org/10.1124/dmd.114.062901
  • You have access
    A Novel Reaction Mediated by Human Aldehyde Oxidase: Amide Hydrolysis of GDC-0834
    Jasleen K. Sodhi, Susan Wong, Donald S. Kirkpatrick, Lichuan Liu, S. Cyrus Khojasteh, Cornelis E. C. A. Hop, John T. Barr, Jeffrey P. Jones and Jason S. Halladay
    Drug Metabolism and Disposition June 2015, 43 (6) 908-915; DOI: https://doi.org/10.1124/dmd.114.061804
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 43 (6)
Drug Metabolism and Disposition
Vol. 43, Issue 6
1 Jun 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Short Communication
  • Accelerated Communication
  • Articles
  • Most Read
Loading
  • Metabolism and Disposition of Volanesorsen across Species
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics